Dr Polina Prokopovich

Dr Polina Prokopovich

Senior Lecturer in Nanotechnology and Advanced Biomaterials, International Mobility Coordinator and Erasmus+ Lead

School of Pharmacy and Pharmaceutical Sciences

Qualifications

  • PhD in Chemical Engineering from Loughborough University (2006)
  • MSc (1st Class Honours) in Physical, Colloid and Surface Science from St Petersburg State University, Russia (2002)
  • BSc (1st Class Honours) in Chemistry from St Petersburg State University, Russia (2000)

Related websites

Community Engagement:

Positions available

A number of Projects (both experimental and computational modelling) are available for Erasmus and self-funded PhD students.

  • 2016-onwards: Senior Lecturer in Nanotechnology and Advanced Biomaterials, School of Pharmacy and Pharmaceutical Sciences, Cardiff University, UK.
  • 2014- 2016: Lecturer in Biomaterials, School of Pharmacy and Pharmaceutical Sciences, Cardiff University, UK.
  • 2011 - 2014: Cardiff Academic Fellow, School of Pharmacy and Pharmaceutical Sciences and School of Engineering. Arthritis Research UK Biomechanics and Bioengineering Centre, Cardiff University, UK.
  • 2010 - 2011:  Research Fellow, Institute of Medical and Biological Engineering, Leeds University, UK.
  • 2008 – 2010:  Research Associate sponsored by Astra Zeneca, Wolfson School of Mechanical and Manufacturing Engineering, Loughborough University, UK
  • 2007:  Scientist, 3M Health Care Ltd, UK.
  • 2003 - 2006 PhD, Chemical Engineering Department, Loughborough University, UK.
  • 2000 - 2002 MSc, Physical, Colloid and Surface Science, St Petersburg State University, Russia.
  • 1997 - 2000 BSc, Chemistry Department, St Petersburg State University, Russia.

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2007

2006

2005

2004

    Undergraduate

    Module leader of PH1121 (Molecule to Patient)

    Personal Tutor

    Contribution to MPharm modules:

  • PH1122  The role of the pharmacist in professional practice
  • PH1123  Structure and function of cells and microbes
  • PH1124  Human body systems
  • PH1000 Professional development
  • PH2107 Formulation Science I
  • PH2113 Diseases and Drugs 1
  • PH2000 Professional development
  • PH2110 Clinical and Professional Pharmacy (OSCEs)
  • PH3114  Design, formulation and quality assurance of medicinal products
  • PH3202  Research methodology
  • PH3000 Professional development
  • PH4116  Pharmacy research or scholarship project
  • EN3060 Biomaterials and Tissue Engineering
  • Postgraduate

  • MSc course - Cancer and Experimental Therapeutics
  • MSc (Erasmus) and PhD student supervision

Current research projects:

Targeted drug delivery for joint diseases

The goal is to achieve Higher drug uptake and Higher retention in the tissue with ability to target disease pathology and to avoids off-target organ toxicity (side effects).

Anti-inflammatory Drug delivery systems to prevent wear particles-induced inflammation

The aim is to prepare anti-inflammatory drug eluting implant model to target inflammation.

Orthopaedic antimicrobial nanocomposite bone cements

Our approach is to fabricate metal and organic NPs with antimicrobial activity and encapsulate them into bone cement formulation producing nanocomposite materials  with functional properties.

Multifunctional hydrogels as bone graft materials

Our approach is to use nanotechnology and polymer chemistry to prepare novel nanocomposite hydrogels with multiple functionality (osseoinductive, osseoconductive and antimicrobial properties).

Nanomechanical and surface properties of cells post exposure to metal, ceramic and polymeric wear particles

Our aim is to achieve a greater depth of knowledge into the adhesive interactions and nanomechanical aspects of cells surrounding implantations which have not been investigated previously, and will require research into adhesion concepts adaptable to biological systems. Considerations for the influence of surface parameters and surface treatments along with their impact on cells nanomechanical and adhesive properties caused by implant debris are investigated.

Research in Dr. Prokopovich’s group is sponsored by:

  • Wellcome Trust
  • Welsh Government
  • Innovate UK
  • EU funds
  • Industries